Literature DB >> 23093528

Laparoscopic partial nephrectomy: The McMaster University experience.

Naji J Touma1, Edward D Matsumoto, Anil Kapoor.   

Abstract

INTRODUCTION: : Laparoscopic partial nephrectomy (LPN) remains one of the more challenging procedures in urology. Minimizing warm ischemia time (WIT) and bleeding requires efficient intracorporeal suturing. In addition, achieving negative surgical margins requires complete excision of the tumour. We report a large Canadian series of laparoscopic partial nephrectomy with intermediate follow-up.
METHODS: : Between September 2000 and August 2008, 152 consecutive laparoscopic partial nephrectomies were performed at our centre. Demographic, pathological and clinical data were collected through a retrospective review of the charts.
RESULTS: : The average tumour size was 2.68 cm (Range: 0.5-8.8. The vast majority of tumours were malignant (80%). All margins were negative, except for 2 patients who underwent an immediate re-resection. There were no local recurrences or distant metastasis during the follow-up period of 44.3 months. Most procedures required hilar clamping (93.4%) with a mean WIT of 34 minutes, with a clear trend for declining WIT with increasing experience. Five procedures were converted to laparoscopic radical nephrectomy, 10 converted to a hand-assisted procedure, and 1 was converted to an open partial nephrectomy. The average blood loss was 162 cc. Complications related to the procedure were classified according to the Clavien grading system. The average drop in the glomerular filtration rate was calculated by the Modification of Diet in Renal Disease (MDRD) Study equation between preoperative and 2.5 months postoperative was 8.6 mL/min/1.73 m(2).
CONCLUSIONS: : LPN is a challenging procedure that requires advanced laparoscopic skills. LPN is feasible with excellent oncological outcomes, and an acceptable complication profile. The short-term impact on overall renal function is minimal. The most common postoperative complication was pseudo-aneurysm requiring embolization, which reinforces the intra-operative need for meticulous and a quick suture-ligation of blood vessels during LPN.

Entities:  

Year:  2012        PMID: 23093528      PMCID: PMC3433534          DOI: 10.5489/cuaj.11256

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  20 in total

1.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

Authors:  William C Huang; Andrew S Levey; Angel M Serio; Mark Snyder; Andrew J Vickers; Ganesh V Raj; Peter T Scardino; Paul Russo
Journal:  Lancet Oncol       Date:  2006-09       Impact factor: 41.316

2.  Partial nephrectomy in the treatment of renal adenocarcinoma.

Authors:  A C Novick; B H Stewart; R A Straffon; L H Banowsky
Journal:  J Urol       Date:  1977-12       Impact factor: 7.450

3.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.

Authors:  A F Fergany; K S Hafez; A C Novick
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

4.  The results of radical nephrectomy for renal cell carcinoma.

Authors:  C J Robson; B M Churchill; W Anderson
Journal:  J Urol       Date:  1969-03       Impact factor: 7.450

5.  Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Authors:  Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

6.  Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

Authors:  W K Lau; M L Blute; A L Weaver; V E Torres; H Zincke
Journal:  Mayo Clin Proc       Date:  2000-12       Impact factor: 7.616

7.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 8.  Laparoscopic versus open partial nephrectomy: analysis of the current literature.

Authors:  Francesco Porpiglia; Alessandro Volpe; Michele Billia; Roberto Mario Scarpa
Journal:  Eur Urol       Date:  2008-01-16       Impact factor: 20.096

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  3 in total

Review 1.  Laparascopic nephrectomy: different techniques and approaches.

Authors:  Tania González León
Journal:  Curr Urol Rep       Date:  2015-02       Impact factor: 3.092

2.  Multidetector CT imaging of complications after laparoscopic nephron-sparing surgery.

Authors:  Massimo Tonolini; Anna Maria Ierardi; Virginia Varca; Giacomo Piero Incarbone; Marina Petullà; Roberto Bianco
Journal:  Insights Imaging       Date:  2015-06-24

3.  A modified adrenal gland-sparing surgery based on retroperitoneal laparoscopic radical nephrectomy.

Authors:  Zhenyu Xu; Zhengyu Zhang; Jianping Gao; Zhifeng Wei; Xiaofeng Xu; Jie Dong; Hao Tang; Xiaoming Yi; Chaopeng Tang; Wenquan Zhou
Journal:  World J Surg Oncol       Date:  2014-06-05       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.